139 related articles for article (PubMed ID: 12665848)
1. Successful treatment of refractory T-cell acute lymphoblastic leukemia by unmanipulated stem cell transplantation from an HLA 3-loci mismatched (haploidentical) sibling.
Ikegame K; Tanji Y; Kitai N; Tamaki H; Kawakami M; Fujioka T; Oka Y; Maruya E; Saji H; Sugiyama H; Ogawa H
Bone Marrow Transplant; 2003 Mar; 31(6):507-10. PubMed ID: 12665848
[TBL] [Abstract][Full Text] [Related]
2. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
Ogawa H; Ikegame K; Yoshihara S; Kawakami M; Fujioka T; Masuda T; Taniguchi Y; Hasei H; Kaida K; Inoue T; Kim EH; Kawase I
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
[TBL] [Abstract][Full Text] [Related]
3. Successful T-cell-replete peripheral blood stem cell transplantation from HLA-haploidentical microchimeric mother to daughter with refractory acute lymphoblastic leukemia using reduced-intensity conditioning.
Umeda K; Adachi S; Ishihara H; Higashi Y; Shiota M; Watanabe KI; Hishizawa M; Ichinohe T; Kitoh T; Maruya E; Saji H; Uchiyama T; Nakahata T
Bone Marrow Transplant; 2003 Jun; 31(11):1061-3. PubMed ID: 12774061
[TBL] [Abstract][Full Text] [Related]
4. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous cord blood transplantation of ex vivo expanded together with non-expanded cells for high risk leukemia.
Kögler G; Nürnberger W; Fischer J; Niehues T; Somville T; Göbel U; Wernet P
Bone Marrow Transplant; 1999 Aug; 24(4):397-403. PubMed ID: 10467329
[TBL] [Abstract][Full Text] [Related]
6. Haploidentical transplantation for acute lymphoblastic leukemia in childhood.
Klingebiel T; Handgretinger R; Lang P; Bader P; Niethammer D
Blood Rev; 2004 Sep; 18(3):181-92. PubMed ID: 15183902
[TBL] [Abstract][Full Text] [Related]
7. HLA-haploidentical nonmyeloablative stem cell transplantation: induction to tolerance without passing through mixed chimaerism.
Ikegame K; Kawakami M; Yamagami T; Maeda H; Onishi K; Taniguchi Y; Fujioka T; Masuda T; Kawase I; Ogawa H
Clin Lab Haematol; 2005 Apr; 27(2):139-41. PubMed ID: 15784130
[TBL] [Abstract][Full Text] [Related]
8. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S
Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562
[TBL] [Abstract][Full Text] [Related]
9. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of primary plasma cell leukaemia by allogeneic stem cell transplantation from haploidentical sibling.
Nonami A; Miyamoto T; Kuroiwa M; Kunisaki Y; Kamezaki K; Takenaka K; Harada N; Teshima T; Harada M; Nagafuji K
Jpn J Clin Oncol; 2007 Dec; 37(12):969-72. PubMed ID: 18055567
[TBL] [Abstract][Full Text] [Related]
11. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.
Guo M; Sun Z; Sun QY; Han Q; Yu CL; Wang DH; Qiao JH; Chen B; Sun WJ; Hu KX; Liu GX; Liu B; Zhao RC; Ai H
Biol Blood Marrow Transplant; 2009 Aug; 15(8):930-7. PubMed ID: 19589482
[TBL] [Abstract][Full Text] [Related]
12. [Acute lymphoblastic leukemia in childhood treated with non-T-cell depleted bone marrow transplantation from an HLA 2 loci (HLA-A and-DRB1)-mismatched mother after early graft failure of cord blood transplantation].
Ishida H; Mori K; Yoshihara T; Shin N; Morimoto A; Imashuku S
Rinsho Ketsueki; 2003 Nov; 44(11):1101-6. PubMed ID: 14689875
[TBL] [Abstract][Full Text] [Related]
13. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
14. [Induction of aGVHD after allogeneic hematopoietic stem cell transplantation for refractory or relapsed acute leukemia].
Sun J; Meng FY; Liu QF; Xu D; Xu B; Liu XL
Ai Zheng; 2003 Dec; 22(12):1321-4. PubMed ID: 14693060
[TBL] [Abstract][Full Text] [Related]
15. Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.
Nordlander A; Mattsson J; Ringdén O; Leblanc K; Gustafsson B; Ljungman P; Svenberg P; Svennilson J; Remberger M
Biol Blood Marrow Transplant; 2004 Mar; 10(3):195-203. PubMed ID: 14993885
[TBL] [Abstract][Full Text] [Related]
16. [Successful donor lymphocyte infusion for Epstein-Barr virus-associated lymphoproliferative disorder after allogeneic bone marrow transplantation from an HLA 1-locus-mismatched sibling donor in a patient with acute lymphocytic leukemia].
Yago K; Itoh M; Shimada H
Rinsho Ketsueki; 2001 Nov; 42(11):1105-10. PubMed ID: 11808079
[TBL] [Abstract][Full Text] [Related]
17. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.
Bishara A; De Santis D; Witt CC; Brautbar C; Christiansen FT; Or R; Nagler A; Slavin S
Tissue Antigens; 2004 Mar; 63(3):204-11. PubMed ID: 14989709
[TBL] [Abstract][Full Text] [Related]
18. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.
Lazarus HM; Koc ON; Devine SM; Curtin P; Maziarz RT; Holland HK; Shpall EJ; McCarthy P; Atkinson K; Cooper BW; Gerson SL; Laughlin MJ; Loberiza FR; Moseley AB; Bacigalupo A
Biol Blood Marrow Transplant; 2005 May; 11(5):389-98. PubMed ID: 15846293
[TBL] [Abstract][Full Text] [Related]
19. Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months.
Eapen M; Rubinstein P; Zhang MJ; Camitta BM; Stevens C; Cairo MS; Davies SM; Doyle JJ; Kurtzberg J; Pulsipher MA; Ortega JJ; Scaradavou A; Horowitz MM; Wagner JE
J Clin Oncol; 2006 Jan; 24(1):145-51. PubMed ID: 16382124
[TBL] [Abstract][Full Text] [Related]
20. HLA-haploidentical umbilical cord blood stem cell transplantation in a child with advanced leukemia: clinical outcome and analysis of hematopoietic recovery.
Miniero R; Busca A; Roncarolo MG; Saitta M; Iavarone A; Timeus F; Biondi A; Amoroso A; Perugini L; Ciuti E
Bone Marrow Transplant; 1995 Aug; 16(2):229-40. PubMed ID: 7581141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
